BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2026468)

  • 1. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia.
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):75-81. PubMed ID: 2026468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.
    Benichou C; Solal Celigny P
    Nouv Rev Fr Hematol (1978); 1991; 33(3):257-62. PubMed ID: 1956763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Criteria of drug-induced liver disorders. Report of an international consensus meeting.
    Bénichou C
    J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee.
    Böttiger LE; Furhoff AK; Holmberg L
    Acta Med Scand; 1979; 205(6):457-61. PubMed ID: 452939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings].
    Solal-Céligny P; Benichou C; Boivin P; Castot A; Coulombel L; Danan G; Degos L; Evreux JC; Lagier G; Lavarenne J
    Nouv Rev Fr Hematol (1978); 1987; 29(4):265-70. PubMed ID: 3320952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic side effects of drugs.
    Lubran MM
    Ann Clin Lab Sci; 1989; 19(2):114-21. PubMed ID: 2665627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced hematological disorders].
    Nishimura J; Motomura S; Akagi T
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():99-105. PubMed ID: 18074523
    [No Abstract]   [Full Text] [Related]  

  • 9. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (X): gastrointestinal system disorders.
    Pharmacoepidemiol Drug Saf; 1998 Jul; 7(4):281-7. PubMed ID: 15073991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group].
    Royer RJ; Benichou C
    Therapie; 1991; 46(3):173-8. PubMed ID: 1792648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XII): collagen disorders and musculo-skeletal disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 Mar; 8(2):141-5. PubMed ID: 15073939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-associated disease: hematologic dysfunction.
    Vandendries ER; Drews RE
    Crit Care Clin; 2006 Apr; 22(2):347-55, viii. PubMed ID: 16678004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XIII): clinical pathology and general disorders.
    Council for International Organization of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 May; 8(3):217-24. PubMed ID: 15073931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxyphenbutazone (Tanderil) and blood dyscrasia.
    Brownlie BE; Strang PJ
    N Z Med J; 1969 Feb; 69(441):77-9. PubMed ID: 5252205
    [No Abstract]   [Full Text] [Related]  

  • 15. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders.
    Bankowski Z
    Pharmacoepidemiol Drug Saf; 1998 Sep; 7(5):351-7. PubMed ID: 15073983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitions of terms for reporting adverse drug reactions (IX): nervous system and psychiatric disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1998 Jan; 7(1):39-49. PubMed ID: 15073745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug allergy damage to the blood ].
    Müller U
    Schweiz Med Wochenschr; 1975 Aug; 105(34):1065-72. PubMed ID: 1166294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced haematological reactions.
    Timoney RF
    Ir Med J; 1978 Nov; 71(17):573-7. PubMed ID: 569137
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-induced blood dyscrasias.
    Eisenhauer LA
    Nurs Clin North Am; 1972 Dec; 7(4):799-808. PubMed ID: 4485732
    [No Abstract]   [Full Text] [Related]  

  • 20. Basic requirements for the use of terms for reporting adverse drug reactions (VIII): renal and urinary system disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1997 May; 6(3):203-11. PubMed ID: 15073789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.